Article
Unveiling New Aspects of Meningococcal Carriage and Disease Prevention.
Journal of clinical microbiology - 1 Jan 2016
Gottfredsson Magnus
Abstract excerpt
Recently, two protein-based vaccines have been approved for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB). It is therefore important to study carefully if and how these pathogens respond to widespread vaccination. Traditionally, meningococci have been classified on the basis of capsular phenotypes, but variable levels of capsule expression can influence the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
